Skip to content
OpenCapital
Get started

Axogen AXGN Enterprise value

Enterprise value at other companies

Baxter International logo
Baxter InternationalBAX
$6.88B-55.6%
Stryker logo
StrykerSYK
$137.35B-12.4%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$2.48B+31.6%
Medtronic logo
MedtronicMDT
$131.22B-3.2%

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.38B+110%
P/S10×+4.2×

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%—
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Calculated from Axogen’s reported figures.

$1.7Bmarket cap+$20.6Mtotal debt−$84.7Mcash and equivalents=$1.66B

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's enterprise value?
Axogen (AXGN) reported enterprise value of $1.66B in Q1 2026.
How has Axogen's enterprise value changed year-over-year?
Axogen's enterprise value increased by 91.4% year-over-year, from $864.71M to $1.66B.
What is the long-term trend for Axogen's enterprise value?
Over 5 years (2020 to 2025), Axogen's enterprise value has grown at a 16.2% compound annual growth rate (CAGR), from $726.81M to $1.54B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.